Bahareh Honarparvar
Overview
Explore the profile of Bahareh Honarparvar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Maphumulo S, Halder A, Govender T, Maseko S, Maguire G, Honarparvar B, et al.
Chem Biol Drug Des
. 2018 Jul;
92(5):1899-1913.
PMID: 30003668
HIV-1 protease (HIV PR) is considered as one of the most attractive targets for the treatment of HIV and the impact of flap dynamics of HIV PR on the binding...
12.
Nizami B, Sarasia E, Momin M, Honarparvar B
IEEE/ACM Trans Comput Biol Bioinform
. 2018 Jul;
16(2):560-568.
PMID: 29990200
Exploring different quantum chemical quantities for lead compounds is an ongoing approach in identifying crucial structural activity related features that are contributing into their biological activities. Herein, activity-related quantum chemical...
13.
Ntombela T, Fakhar Z, Ibeji C, Govender T, Maguire G, Lamichhane G, et al.
J Comput Aided Mol Des
. 2018 May;
32(6):687-701.
PMID: 29845435
Tuberculosis remains a dreadful disease that has claimed many human lives worldwide and elimination of the causative agent Mycobacterium tuberculosis also remains elusive. Multidrug-resistant TB is rapidly increasing worldwide; therefore,...
14.
An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant
Sanusi Z, Govender T, Maguire G, Maseko S, Lin J, Kruger H, et al.
J Comput Aided Mol Des
. 2018 Feb;
32(3):459-471.
PMID: 29397520
The aspartate protease of the human immune deficiency type-1 virus (HIV-1) has become a crucial antiviral target in which many useful antiretroviral inhibitors have been developed. However, it seems the...
15.
Fakhar Z, Govender T, Maguire G, Lamichhane G, Walker R, Kruger H, et al.
Mol Biosyst
. 2017 May;
13(6):1223-1234.
PMID: 28480928
Despite the advances in tuberculosis treatment, TB is still one the most deadly infectious diseases and remains a major global health quandary. Mycobacterium tuberculosis (Mtb) is the only known mycobacterium...
16.
Nizami B, Sydow D, Wolber G, Honarparvar B
Mol Biosyst
. 2016 Oct;
12(11):3385-3395.
PMID: 27722739
Regardless of advances in anti-HIV therapy, HIV infection remains an immense challenge due to the rapid onset of mutation instigating drug resistance. Rilpivirine is a second generation di-aryl pyrimidine (DAPY)...
17.
Lawal M, Govender T, Maguire G, Honarparvar B, Kruger H
J Mol Model
. 2016 Sep;
22(10):235.
PMID: 27604278
Implementation of catalysts to drive reactions from reactants to products remains a burden to synthetic and organic chemists. In spite of investigations into the kinetics and mechanism of catalyzed esterification...
18.
Goodarzi M, Coelho L, Honarparvar B, Ortiz E, Duchowicz P
Ecotoxicol Environ Saf
. 2016 Feb;
128:52-60.
PMID: 26890190
The application of molecular descriptors in describing Quantitative Structure Property Relationships (QSPR) for the estimation of vapor pressure (VP) of pesticides is of ongoing interest. In this study, QSPR models...
19.
Fakhar Z, Naiker S, Alves C, Govender T, Maguire G, Lameira J, et al.
J Biomol Struct Dyn
. 2015 Nov;
34(11):2399-417.
PMID: 26612108
An alarming rise of multidrug-resistant Mycobacterium tuberculosis strains and the continuous high global morbidity of tuberculosis have reinvigorated the need to identify novel targets to combat the disease. The enzymes...
20.
Rauf S, Arvidsson P, Albericio F, Govender T, Maguire G, Kruger H, et al.
Org Biomol Chem
. 2015 Aug;
13(39):9993-10006.
PMID: 26289381
N-Methylation has a significant impact on improving the oral bioavailability, lipophilicity and aqueous solubility of peptide-based lead drug structures. The selected mono-amino acid derivatives Ac-X-OMe, where X = Gly, Val,...